Stem cell engineering for regeneration of bone tissue

Stem Cell Engineering: Principles and Applications

Volumn , Issue , 2011, Pages 383-399

  Gelinsky, Michael ^a,b   Lode, Anja ^a   Bernhardt, Anne ^a   Rösen Wolff, Angela ^b,c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

(Human) mesenchymal stem cells, (h)MSC; Biomimetic collagen hydroxyapatite composites (biomimetic mineralised collagen scaffolds); Bone remodelling; Chemoattraction; Co culture; In situ tissue engineering; Osteoclasts (osteoclast like cells); Osteogenic differentiation; Stromal derived factor 1 (SDF 1 ); Tissue engineering

Indexed keywords

EID: 84879499427     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-11865-4_17     Document Type: Chapter

References (73)

1. Arthur A, Zannettino A, Gronthos S. The therapeutic applications of multipotent mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol. 2009;218:237-245.
2. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med. 2004;8:301-316.
3. Beresford JN, Joyner CJ, Devlin C, Triffitt JT. The effects of dexamethasone and 1, 25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol. 1994;39:941-947.
4. Bernhardt A, Lode A, Boxberger S, Pompe W, Gelinsky M. Mineralised collagen - an artificial, extracellular bone matrix - improves osteogenic differentiation of bone marrow stromal cells. J Mater Sci Mater Med. 2008;19:269-275.
5. Bernhardt A, Lode A, Mietrach C, Hempel U, Hanke T, Gelinsky M. In vitro osteogenic potential of human bone marrow stromal cells cultivated in porous scaffolds from mineralised collagen. J Biomed Mater Res A 2008;90A:852-862.
6. Bhakta S, Hong P, Koc O. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovasc Revasc Med. 2006;19-24.
7. Bieback K, Kern S, Klüter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004;22:625-634.
8. Bieback K, Klüter H. Mesenchymal stromal cells from umbilical cord blood. Curr Stem Cell Res Ther. 2007;2:310-323.
9. Bielby R, Jones E, McGonagle D. The role of mesenchymal stem cells in maintenance and repair of bone. Injury 2007;38(Suppl 1):26-32.
10. Bjerre L, Bünger CE, Kassem M, Mygind T. Flow perfusion culture of human mesenchymal stem cells on silicate-substituted tricalcium phosphate scaffolds. Biomaterials 2008;29:2616-2627.
11. Van Den Bos C, Mosca JD, Winkles J, Kerrigan L, Burgess WH, Marshak DR. Human mesenchymal stem cells respond to fibroblast growth factors. Hum Cell 1997;10:45-50.
12. Bradt JH, Mertig M, Teresiak A, Pompe W. Biomimetic mineralization of collagen by combined fibril assembly and calcium phosphate formation. Chem Mater. 1999;11:2694-2701.
13. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem. 1997;64:278-294.
14. Burth R, Gelinsky M, Pompe W. Collagen-hydroxyapatite tapes - a new implant material. Tech Textile. 1999;8:20-21.
15. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9:641-650.
16. Devine SM. Mesenchymal stem cells: will they have a role in the clinic? J Cell Biochem Suppl. 2002;38:73-79.
17. Derubeis AR, Cancedda R. Bone marrow stromal cells (BMSCs) in bone engineering: limitations and recent advances. Ann Biomed Eng. 2004;32:160-165.
18. Diefenderfer DL, Osyczka AM, Reilly GC, Leboy PS. BMP responsiveness in human mesenchymal stem cells. Connect Tissue Res. 2003;44(Suppl 1):305-311.
19. D'Ippolito G, Schiller PC, Perez-Stable C, Balkan W, Roos BA, Howard GA. Cooperative actions of hepatocyte growth factor and 1, 25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cells. Bone 2002;31:269-275.
20. Domaschke H, Gelinsky M, Burmeister B, Fleig R, Hanke T, Reinstorf A, Pompe W, Rösen-Wolff A. In vitro ossification and remodeling of mineralized collagen I scaffolds. Tissue Eng. 2006;12, 949-958.
21. Drosse I, Volkmer E, Capanna R, De Biase P, Mutschler W, Schieker M. Tissue engineering for bone defect healing: an update on a multi-component approach. Injury 2008;39S2:S9-S20.
22. Eghbali-Fatourechi GZ, Mödder UIL, Charatcharoenwitthaya N, Sanyal A, Undale AH, Clowes JA, Tarara JE, Khosla S. Characterization of circulating osteoblast lineage in humans. Bone 2007;40:1370-1377.
23. Erratum: Bone 2007;41:741.
24. Erlebacher A, Filvaroff EH, Ye JQ, Derynck R. Osteoblastic responses to TGF-beta during bone remodeling. Mol Biol Cell 1998;9:1903-1918.
25. Fiedler J, Roderer G, Gunther KP, Brenner RE. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem. 2002;87:305-312.
26. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267-274.
27. Friedman MS, Long MW, Hankenson KD. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem. 2006;98:538-554.
28. Gelinsky M, Welzel PB, Simon P, Bernhardt A, König U. Porous three dimensional scaffolds made of mineralised collagen: preparation and properties of a biomimetic nanocomposite material for tissue engineering of bone. Chem Eng J. 2008;137:84-96.
29. Gelinsky M. Mineralised collagen as biomaterial and matrix for bone tissue engineering. In: Meyer U, Handschel J, Wiesmann HP, Meyer Th eds. Fundamentals of tissue engineering and regenerative medicine. Heidelberg and Berlin: Springer; 2009; chapter 36, 485-493.
30. Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol. 2007;211:27-35.
31. Handschel J, Wiesmann HP, Depprich R, Kübler NR, Meyer U. Cell-based bone reconstruction therapies - cell sources. Int J Oral Maxillofac Impl. 2006;21:890-898.
32. Heng BC, Tong C, Stanton LW, Robson P, Olsen B. Strategies for directing the differentiation of stem cells into the osteogenic lineage in vitro. J Bone Miner Res. 2004;19:1379-1394.
33. Hong L, Colpan A, Peptan IA. Modulations of 17-beta estradiol on osteogenic and adipogenic differentiations of human mesenchymal stem cells. Tissue Eng. 2006;12:2747-2753.
34. Hong L, Colpan A, Peptan IA, Daw J, George A, Evans CA. 17-Beta estradiol enhances osteogenic and adipogenic differentiation of human adipose-derived stromal cells. Tissue Eng. 2007;13:1197-1203.
35. Igura K, Zhang X, Takahashi K, Mitsuru A, Yamaguchi S, Takashi TA. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy 2004;6:543-553.
36. Jagodzinski M, Drescher M, Zeichen J, Hankemeier S, Krettek C, Bosch U, Van Griensven M. Effects of cyclic longitudinal mechanical strain and dexamethasone on osteogenic differentiation of human bone marrow stromal cells. Eur Cells Mater. 2004;7:35-41.
37. Jagodzinski M, Breitbart A, Wehmeier M, Hesse E, Haasper C, Krettek C, Zeichen J, Hankemeier S. Influence of perfusion and cyclic compression on proliferation and differentiation of bone marrow stromal cells in 3-dimensional culture. J Biomech. 2008;41:1885-1891.
38. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem. 1997;64:295-312.
39. Jones E, McGonagle D. Human bone marrow mesenchymal stem cells in vivo. Rheumatology 2008;47:126-131.
40. Kanczler JM, Oreffo RO. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater. 2008;15:100-114.
41. Kauser K, Zeiher AM eds. Bone marrow-derived progenitors. Handbook of experimental pharmacology. Berlin and Heidelberg: Springer; 2007.
42. Koshla S, Eghbali-Fatourechi GZ. Circulating cells with osteogenic potential. Ann NY Acad Sci. 2006;1068:489-497.
43. Kundu AK, Putnam AJ. Vitronectin and collagen I differentially regulate osteogenesis in mesenchymal stem cells. Biochem Biophys Res Commun. 2006;347:347-357.
44. Lee KD. Applications of mesenchymal stem cells: an updated review. Chang Gung Med J. 2008;31:228-236.
45. Lendeckel S, Jödicke A, Christophis P, Heidinger K, Wolff J, Fraser JK, Hedrick MH, Berthold L, Howaldt HP. Autologous stem cells (adipose) and fibrin glueused to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg. 2004;32:370-377.
46. Liu P, Oyajobi BO, Russell RG, Scutt A. Regulation of osteogenic differentiation of human bone marrow stromal cells: interaction between transforming growth factor-beta and 1, 25 (OH) (2) vitamin D (3) In vitro. Calcif Tissue Int. 1999;65:173-180.
47. Lode A, Bernhardt A, Boxberger S, Gelinsky M. Cultivation of mesenchymal stem cells on a three-dimensional artificial extracellular bone matrix. Proceedings of the International Conference "Biomaterials in Regenerative Medicine", Nadolny AJ, ed. Conference Proceedings and Monographs, Vienna Scientific Centre of the Polish Academy of Sciences, Vienna 2006, Vol. 6, 167-172.
48. Lode A, Bernhardt A, Gelinsky M. Cultivation of human bone marrow stromal cells on three-dimensional scaffolds of mineralized collagen: influence of seeding density on colonization, proliferation and osteogenic differentiation. J Tissue Eng Reg Med. 2008;2:400-407.
49. Lucarelli E, Donati D, Cenacchi A, Fornasari PM. Bone reconstruction of large defects using bone marrow derived autologous stem cells. Transfus Apher Sci. 2004;30:169-174.
50. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 1997;138:4456-4462.
51. Ng AM, Saim AB, Tan KK, Tan GH, Mokhtar SA, Rose IM, Othman F, Idrus RB. Comparison of bioengineered human bone constructs from four sources of osteogenic cells. J Orthop Sci. 2005;10:192-199.
52. Owen M. Marrow stromal stem cells. J Cell Sci Suppl. 1988;10:63-76.
53. Patel ZS, Mikos AG. Angiogenesis with biomaterial-based drug-and cell-delivery systems. J Biomater Sci Polym Ed. 2004;15:701-726.
54. Pauwels F. Eine neue Theorie über den Einfluß mechanischer Reize auf die Differenzierung der Stützgewebe. Z Anat Entwicklungsgesch. 1960;121:478-515 (in German).
55. Philips AM. Overview of the fracture healing cascade. Injury 2005;36S:S5-S7.
56. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
57. Pri-Chen S, Pitaru S, Lokiec F, Savion N. Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrowderived bone-like cells in culture. Bone 1998;23:111-117.
58. Ramoshebi LN, Matsaba TN, Teare J, Renton L, Patton J, Ripamonti U. Tissue engineering: TGF-beta superfamily members and delivery systems in bone regeneration. Expert Rev Mol Med. 2002;4:1-11.
59. Roelen BA, Dijke P. Controlling mesenchymal stem cell differentiation by TGF beta family members. J Orthop Sci. 2003;8:740-748.
60. Ryser MF, Ugarte F, Thieme S, Bornhäuser M, Roesen-Wolff A, Brenner S. mRNA transfection of a CXCR4-GFP fusion protein - generated by a simple three step PCR protocol - results in efficient migration of primary mesenchymal stem cells. Tissue Eng Part C 2008;14:179-184.
61. Sammons J, Ahmed N, El-Sheemy M, Hassan HT. The role of BMP-6, IL-6, and BMP-4 in mesenchymal stem cell-dependent bone development: effects on osteoblastic differentiation induced by parathyroid hormone and vitamin D (3). Stem Cells Dev. 2004;13:273-280.
62. Sata M, Tanaka K, Nagai R. Circulating osteoblast-lineage cells. N Engl J Med. 2005;353:737-738.
63. Schantz JT, Chim H, Whiteman M. Cell guidance in tissue engineering: SDF-1 mediates site-directed homing of mesenchymal stem cells within three-dimensional polycaprolactone scaffolds. Tissue Eng. 2007;13:2615-2624.
64. Schwartz Z, Simon BJ, Duran MA, Barabino G, Chaudhri R, Boyan BD. Pulsed electromagnetic fields enhance BMP-2 dependent osteoblastic differentiation of human mesenchymal stem cells. J Orthop Res. 2008;26:1250-1255.
65. Sen MK, Miclau T. Autologous iliac crest bone graft: should it still be the gold standard for treating nonunsions? Injury 2007;38S1:S75-S80.
66. Thibault MM, Hoemann CD, Buschmann MD. Fibronectin, vitronectin, and collagen I induced chemotaxis and haptotaxis of human and rabbit mesenchymal stem cells in a standardized transmembrane assay. Stem Cells Dev. 2007;16:489-502.
67. Thieme S, Ryser M, Gentsch M, Brenner S, Stiehler M, Rölfing J, Gelinsky M, Rösen-Wolff A. Stromal cell derived factor-1a directed chemoattraction of transiently CXCR4 overexpressing mesenchymal stem cells into functionalised three-dimensional biomimetic scaffolds. Tissue Eng Part C 2009;15:687-696.
68. Tsiridis E, Bhalla A, Ali Z, Gurav N, Heliotis M, Deb S, DiSilvio L. Enhancing the osteoinductive properties of hydroxyapatite by the addition of human mesenchymal stem cells, and recombinant human osteogenic protein-1 (BMP-7) in vitro. Injury 2006;37(Suppl 3):S25-S32.
69. Wahl DA, Czernuszka JT. Collagen-hydroxyapatite composites for hard tissue repair. Eur Cell Mater. 2006;11:43-56.
70. Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 2006;20:1915-1924.
71. Wynn RF, Hart CA, Corradi-Perini C, O'Neill L, Evans CA, Wraith JE, Fairbairn LJ, Bellantuono I. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004;104:2643-2645.
72. Zhang D, Fan GC, Zhou X, Zhao T, Pasha Z, Xu M, Zhu Y, Ashraf M, Wang Y. Overexpression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol. 2008;44:281-292.
73. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295.